|
Worldwide
Alert For Avian Influenza (Bird Flu)
There is a new
strain of avian influenza that in the beginning was confined to
transmission among birds only. However, with 8 deaths in humans
reported in Asia by the end of January 2004 (7 children and one
adult) there is a fear that the virus is possibly genetically adapting
towards transmission between humans, which could cause a worldwide
flu epidemic similar to the flu in 1918 where more than 40 million
people died.
Presently the
avian flu has killed a high percentage of chickens and ducks in
Vietnam, China, Thailand, Indonesia, Pakistan, Cambodia, and Laos.
Recently Japan, South Korea, and Taiwan have also been added to
the countries where the avian flu has arrived in birds. The governments
are busy killing chickens off by the millions in an attempt to stop
transmission to man.
All of the human
cases were found in people who lived close to chicken farms or who
handled diseased chickens.
The virus strain has been characterized as the type A, H5N1 strain
(= the H5N1 flu), of the avian influenza. This strain has surfaced
in the past on two occasions. First, it hit 18 persons in Hong Kong
in 1997 of which 8 persons died. With the help of strict isolation
methods an epidemic was prevented. Secondly, in March of 2003 a
father and son from Hong Kong had traveled to southern China and
they returned sick with the flu. The father died, the son recovered.
Disease investigation showed that the source of infection in all
of these cases was contact with diseased birds or with live, infected
poultry in open markets.
Unfortunately
the present flu vaccines will not give protection against this strain.
WHO officials had an emergency meeting at the end of January 2004
to discuss the strategy for preventing a worldwide epidemic with
this new influenza strain. Production of a new vaccine will take
several months (up to 6 to 8 months), if it is done in the conventional
way. The cheaper antiviral antibiotics such as amantadine and rimantadine
that normally would cover an A type influenza are ineffective against
this new flu strain. There are newer antiviral antibiotics, which
are effective, but they are more expensive. With mass production
they could become more affordable and this could interfere with
the spread between humans, if the virus should adapt to this transmission
behavior.
At the present
time migratory birds that are infected with the flu virus are spreading
the avian flu to birds in other neighboring countries. In the meantime
farmers who are not satisfied with only a 10% reimbursement by their
governments for forcefully killed chickens are selling chickens
on open meat markets, some of which harbor the avian flu, and this
is another possible mode of transmission. David
A. Halvorson, a veterinary medicine doctor from the University of
Minnesota in Saint Paul stated that the risk for avian flu in the
US at the present time is low as the US is not importing any live
poultry from Asia.
In an interview
between Doug Kaufman from MD Consult and the CDC director Dr. Julie
Gerberding on Jan. 29, 2004 it was learnt that 10 patients had died
so far in Vietnam and Thailand. Six WHO scientist in Vietnam are
working with officials to contain the avian flu in Asia so that
it won't migrate similar to another outbreak of the same type of
avian flu strain in Hong Kong in 1997. It appears that the killing
of chickens has made some difference. On the other hand the spreading
of the disease among wild ducks is of some concern.
The CDC and
WHO are working together on this and are pushing for accelerated
production of live and of inactivated vaccines against avian flu.
This is a type of vaccine, which would make it impossible for future
avian flu strains to cross into human hosts. The mass production
of antiviral drugs is also being pursued. Dr. Gerberding stated
that oseltamivir (brand name: Tamiflu), one of the newer antiviral
drugs, would be effective in treating this type of avian flu (cited
in Medscape Medical News Jan. 29, 2004).
Dr. Neill, an
infection specialist and professor of medicine at the Brown University
School of Medicine in Providence, Rhode Island, said that in case
of a future human breakout of an epidemic with this flu the following
instructions should be followed: 1. cover your mouth and nose with
paper tissue when you sneeze or cough 2. frequently wash your hands
with soap and water 3. use designated containers for disposal of
the used paper tissues 4. symptomatic patients should use face masks
to prevent the spread of the flu.
This
article is based on the Lancet (The Journal) Vol. 363, Vol. 9406
(Jan. 31, 2004), on news stories from MD Consult and on Medscape
news stories.
Link to Centers
for Disease Control and Prevention on avian (bird) flu
More detail
about this present flu (also CDC site)
|
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§
|
Low
Testosterone Linked To Alzheimers
A recent publication
in the medical journal Neurology by Dr. Susan Resnick revealed a
surprise link between a lack of testosterone and Alzheimers disease.
574 men from
the Baltimore Longitudinal Study of Aging who had been followed
for about 19 years were analyzed with respect to hormonal factors
and their neurological status was also observed. Of these men who
ranged in age from 32 to 87 years initially 54 were diagnosed with
Alzheimers disease.
When the researchers
looked at the hormone status of the men whose mental functioning
stayed stable versus those who developed Alzheimers, it was clear
that the height of the free testosterone level in the blood
(expressed by dividing testosterone by the sex hormone-binding globulin)
was a significant predictor for not getting Alzheimers. In
other words, if men could maintain a stable level of free testosterone
with aging they were significantly protected from Alzheimers disease.
The effect was so marked that the blood test could predict 10-years
in advance whether a man would develop Alzheimers in future or not.
There was a 26% reduction in the risk of Alzheimers with each 10-unit
increase in free testosterone.
The same edition
of Neurology contains a second report by Dr. Gian Benedetto Melis
and coworkers (University of Cagliari, Italy) where around 100 patients
(males and females) with Alzheimers were compared with a similar
number of patients without Alzheimers. All of their body mass index
was in the normal range (20 to 22). These researchers found that
the Alzheimers group (both male and female) had an extremely high
sex hormone-binding globulin. The testicles in males and the adrenal
glands in males and females can produce testosterone. Dr. Resnick
remarked that free testosterone can enter the brain tissue (via
the blood brain barrier) easily and act directly on the brain or
can be converted to estrogen. Estrogen has been shown in other studies
to have a protective effect against Alzheimers. Dr. Resnick cautioned
that another study where males with low testosterone levels are
getting testosterone supplementation has to be done first before
a male should be advised to get treated with testosterone for prevention
of Alzheimers disease.
This article
is based on a publication by Dr. Resnick et al. in Neurology 2004;62:188-193,301-303.
Comments:
It is interesting to note that the "old fashioned"
remedies such as weight loss, exercise (particularly anaerobic exercises
such as weight training) and a low glycemic diet will naturally
increase testosterone levels and vitality in both sexes. A comprehensive
program such as the zone diet (by Dr. Barry Sears) or a similar
such low glycemic program when combined with exercise will automatically
make you lose weight down to a normal body mass index and allow
you to maintain it without hunger pangs. It will also normalize
hormones in most people on its own as previously elevated insulin
levels normalize and the sex hormone-binding globulin will normalize
as well. This will make the necessary hormones available to you
whether female or male, will prevent osteoporosis (from exercise)
and provide enough hormones before and after menopause or andropause
to most people. Only a minority of patients will need to get blood
tests from their doctors depending on symptoms and those need to
seek medical advice to see whether they might benefit from hormone
replacement therapy.
|
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§
|
Kidney
Disease, Another Complication Of Metabolic Syndrome
The metabolic
syndrome
is a new disease entity that is known to be associated
with obesity. In order to make the diagnosis of metabolic syndrome
at least 3 of the 5 components listed in the table under this link
(hypertension, hypertriglyceridemia, low high-density lipoprotein
cholesterol level or LDL cholesterol, high glucose level, abdominal
obesity) have to be present.
Dr. Jing Chen
and colleagues of Tulane University School of Medicine in New Orleans,
La., published an analysis of the Third National Health and Nutrition
Examination Survey in the Feb.3, 2004 edition of the Annals of Medicine.
Patients with chronic kidney disease were identified in this study
where 3, 4 or 5 of the metabolic syndrome criteria were positive.
Two criteria for chronic kidney disease were measured:
1. if there
was a significant reduction of the filtration capacity of the kidney.
2. if there
was critical leakage of blood protein into the urine.
Depending on
how advanced the metabolic syndrome was (all 5 criteria of metabolic
syndrome positive versus only 3 or 4) there was a higher or lower
risk of developing chronic kidney disease.
| Risk
of developing kidney disease with various degrees of severity
of the metabolic syndrome |
 |
I have depicted
the results of this study in bar graph form here. It shows clearly
that chronic kidney damage occurs in a dose-response curve pattern
depending on how severe the degree of the metabolic syndrome is.
With 5 factors of the metabolic syndrome present the risk to develop
reduction in filtration capacity of the kidneys is almost 6-fold.
This is 3-fold higher than in a person with a milder degree of metabolic
syndrome where only two factors are present. Such a person would
only have a 2-fold risk for developing chronic kidney damage (dark
blue shaded bars in graph). A dipstick urine test can measure protein
in urine, which is an alternative way to measure kidney damage due
to the metabolic syndrome. These values followed a very similar
dose-response curve (light blue shaded bars in graph). The authors
of this study believe that the kidney damage inflicted by the metabolic
syndrome is different from that caused by high blood pressure or
by diabetes. Future studies will have to establish whether this
type of kidney damage can be repaired by treating the metabolic
syndrome with a low glycemic, calorie restricted diet coupled with
exercise.
Based on
an article published in: Ann Intern Med 2004:140:167-174.
|
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§
|
Cinnamon
A Natural Insulin Booster For Diabetics
In a recent
edition of the medical journal Diabetes Care an interesting article
appeared regarding the healing effects of the spice cinnamon. A
medical research team in Pakistan (Dr. Khan et al.) in collaberation
with a U.S. research team divided a group of 60 comparable diabetics
(males and females) in the age range of 45 to 55 and fed one half
different concentrations of cinnamon while the other half served
as a placebo control. There were three different concentrations
of capsules of cinnamon given: 1g, 3 g and 6 g. The placebo control
group got capsules with inert material. Here are the results:
| Effect
of cinnamon on blood values of diabetics |
| Blood
component investigated: |
%
Reduction of blood test: |
| Blood
sugar level |
18-29
% |
| Triglycerides
(blood fat value) |
23-30% |
| LDL
cholesterol (damaging cholesterol) |
7-27% |
| Total
cholesterol |
12-26% |
| HDL
cholesterol (protective cholesterol) |
unchanged |
The placebo
control group showed no change in blood values. The effect documented
in this table was achieved after 40 days of cinnamon exposure and
was "washed out" after 20 days. Other experiments had
found that the substance MHCP (methylhydroxychalcone polymer) is
the active ingredient in cinnamon that stimulates insulin and also
acts on insulin receptors similar to insulin.
Dr. Richard
A. Anderson and his colleagues at the Human Nutrition Research Center
of the U.S. Department of Agriculture had already published a number
of medical papers on the effects of cinnamon. He was the co-author
of this study from the Department of Human Nutrition, NWFP Agricultural
University of Peshawar, Pakistan.
The interesting
observation here is that several cardiovascular risk factors (blood
sugar, triglycerides and LDL cholesterol) are simultaneously being
reduced with something as simple as cinnamon powder. The authors
stated that the cinnamon oil is not effective, only the cinnamon
powder or a cinnamon stick dipped into tea (the water soluble component
of cinnamon or MHCP). Dr. Anderson also warned not to make the mistake
to eat more cinnamon buns or apple pie as there would be unhealthy
amounts of sugar, starch and fat added. He suggested that the best
to do instead would be to simply sprinkle cinnamon powder over whatever
you are presently eating, as this will reduce the risk of getting
diabetes or will reduce the risk of a heart attack in diabetics.
This article
based on: "Cinnamon improves glucose and lipids of people with
type 2 diabetes." Diabetes Care - 01-DEC-2003; 26(12): 3215-8.
Here is a link
to diabetes
mellitus (type
2 diabetes).
|
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§
|
Less
Multiple Sclerosis (MS) With Vitamin D Supplement
In multiple
sclerosis (MS) the body's immune system appears to
attack the insulation material of nerve cells
leading to areas of focal inflammation. These areas can be depicted
with MRI scans. A new study showed that vitamin D
supplementation (as part of a multivitamin supplement) was reducing
the risk of developing MS in women when compared to women who did
not take supplements. This study was published by Munger et al.
from the Department of Nutrition, Harvard School of Public Health,
Boston/MA, in the Jan. 13, 2004 edition of Neurology.
The study is
based on data from two large nurses health studies (NHS with 92,253
women followed from 1980 to 2000 and NHSII with 95,310 women followed
from 1991 to 2001). The study material was pooled into one database.
Among these 187,563 women 173 developed MS during the course of
the original studies. When the group of women who took 400 IU
or more of Vit.D supplements (as multivitamins) were compared
to the group who took less than 400 IU or none, the
investigators found that they were 40% less likely to develop
MS. Other factors that can lead to higher frequencies of MS
such as smoking or latitude at birth had been adjusted for. There
has not been a change in the results of the protective effect of
Vit.D. With food being the only source for vitamin D (skim milk,
fish) the protective effect against MS was not demonstrable. However,
when food vitamin D was combined with additional multiple vitamin
tablets (with vitamin D) the protective effect against MS was observed.
In the introduction
the authors pointed out that Vit. D has been shown in other studies
to be an immune response modulator weakening autoimmune reactions.
This effect has been shown clearly in a mouse model of MS, called
experimental autoimmune encephalopathy. There are also data available
from human research, which showed that certain cytokines are released
in the presence of vitamin D so that the immune cells are less likely
to attack the brain tissue. There were also seasonal variations
that could be demonstrated in this study, which indicated that MS
lesions were progressing at times when vitamin D levels were low
and that they were regressing when vitamin D levels were high.
The authors
of this study stressed that this is the first study to suggest a
protective effect of vitamin D against MS, which would have to be
confirmed in other studies that preferably would also include males.
It shows a very strong statistical connection, but cannot conclusively
prove causation. The investigators said that further studies will
also be needed to confirm the notion that vitamin D may be beneficial
as part of the treatment in MS patients.
|
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§
|
|